173 related articles for article (PubMed ID: 15756540)
1. Vascular damage induced by type 2 diabetes mellitus as a risk factor for benign prostatic hyperplasia.
Berger AP; Deibl M; Halpern EJ; Lechleitner M; Bektic J; Horninger W; Fritsche G; Steiner H; Pelzer A; Bartsch G; Frauscher F
Diabetologia; 2005 Apr; 48(4):784-9. PubMed ID: 15756540
[TBL] [Abstract][Full Text] [Related]
2. Vascular damage as a risk factor for benign prostatic hyperplasia and erectile dysfunction.
Berger AP; Deibl M; Leonhartsberger N; Bektic J; Horninger W; Fritsche G; Steiner H; Pelzer AE; Bartsch G; Frauscher F
BJU Int; 2005 Nov; 96(7):1073-8. PubMed ID: 16225531
[TBL] [Abstract][Full Text] [Related]
3. Atherosclerosis as a risk factor for benign prostatic hyperplasia.
Berger AP; Bartsch G; Deibl M; Alber H; Pachinger O; Fritsche G; Rantner B; Fraedrich G; Pallwein L; Aigner F; Horninger W; Frauscher F
BJU Int; 2006 Nov; 98(5):1038-42. PubMed ID: 16879445
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced transrectal ultrasound for assessing vascularization of hypoechoic BPH nodules in the transition and peripheral zones: comparison with pathological examination.
Yang JC; Tang J; Li Y; Fei X; Shi H
Ultrasound Med Biol; 2008 Nov; 34(11):1758-64. PubMed ID: 18524461
[TBL] [Abstract][Full Text] [Related]
5. Vascular resistance in the prostate evaluated by colour Doppler ultrasonography: is benign prostatic hyperplasia a vascular disease?
Berger AP; Horninger W; Bektic J; Pelzer A; Spranger R; Bartsch G; Frauscher F
BJU Int; 2006 Sep; 98(3):587-90. PubMed ID: 16796699
[TBL] [Abstract][Full Text] [Related]
6. Correlations among cardiovascular risk factors, prostate blood flow, and prostate volume in patients with clinical benign prostatic hyperplasia.
Chen IH; Tsai YS; Tong YC
Urology; 2012 Feb; 79(2):409-14. PubMed ID: 22137544
[TBL] [Abstract][Full Text] [Related]
7. Prostatic vascular damage induced by cigarette smoking as a risk factor for recovery after holmium laser enucleation of the prostate (HoLEP).
Xu H; Liu C; Gu M; Chen Y; Cai Z; Chen Q; Wang Z
Oncotarget; 2017 Feb; 8(8):14039-14049. PubMed ID: 27732940
[TBL] [Abstract][Full Text] [Related]
8. Does benign prostatic hyperplasia originate from the peripheral zone of the prostate? A preliminary study.
Tang J; Yang JC; Zhang Y; Liu X; Zhang L; Wang Z; Li J; Luo Y; Xu J; Shi H
BJU Int; 2007 Nov; 100(5):1091-6. PubMed ID: 17922787
[TBL] [Abstract][Full Text] [Related]
9. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia.
Hammarsten J; Högstedt B
Eur Urol; 2001 Feb; 39(2):151-8. PubMed ID: 11223674
[TBL] [Abstract][Full Text] [Related]
10. The measurement of the prostatic resistive index is a reliable ultrasonographic tool to stratify symptoms of patients with benign prosthatic hyperplasia.
Yencilek E; Koyuncu H; Arslan D; Bastug Y
Med Ultrason; 2014 Sep; 16(3):208-13. PubMed ID: 25110761
[TBL] [Abstract][Full Text] [Related]
11. Effect of tadalafil once daily on prostate blood flow and perfusion in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: a randomized, double-blind, multicenter, placebo-controlled trial.
Pinggera GM; Frauscher F; Paduch DA; Bolyakov A; Efros M; Kaminetsky J; Da Pozzo L; Esler A; Cox D
Urology; 2014 Aug; 84(2):412-9. PubMed ID: 24938580
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the resistive index of prostatic blood flow in benign prostatic hyperplasia.
Abdelwahab O; El-Barky E; Khalil MM; Kamar A
Int Braz J Urol; 2012; 38(2):250-5; discussion 255-7. PubMed ID: 22555031
[TBL] [Abstract][Full Text] [Related]
13. Is transition zone biopsy valuable in benign prostatic hyperplasia patients with serum prostate-specific antigen >10 ng/ml and prior negative peripheral zone biopsy?
Abdel-Khalek M; Sheir KZ; El-Baz M; Ibrahiem el-H
Scand J Urol Nephrol; 2005; 39(1):49-55. PubMed ID: 15764271
[TBL] [Abstract][Full Text] [Related]
14. Role of Doppler ultrasound and resistive index in benign prostatic hypertrophy.
Tsuru N; Kurita Y; Masuda H; Suzuki K; Fujita K
Int J Urol; 2002 Aug; 9(8):427-30. PubMed ID: 12225338
[TBL] [Abstract][Full Text] [Related]
15. Effects of age and sex hormones on transition and peripheral zone volumes of prostate and benign prostatic hyperplasia in twins.
Meikle AW; Stephenson RA; Lewis CM; Middleton RG
J Clin Endocrinol Metab; 1997 Feb; 82(2):571-5. PubMed ID: 9024256
[TBL] [Abstract][Full Text] [Related]
16. "BPSA," a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia.
Mikolajczyk SD; Millar LS; Wang TJ; Rittenhouse HG; Wolfert RL; Marks LS; Song W; Wheeler TM; Slawin KM
Urology; 2000 Jan; 55(1):41-5. PubMed ID: 10654892
[TBL] [Abstract][Full Text] [Related]
17. Measuring resistance index in patients with BPH and lower urinary tract symptoms.
Ozdemir H; Onur R; Bozgeyik Z; Orhan I; Ogras MS; Ogur E
J Clin Ultrasound; 2005 May; 33(4):176-80. PubMed ID: 15856514
[TBL] [Abstract][Full Text] [Related]
18. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
Hammarsten J; Högstedt B
Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
[TBL] [Abstract][Full Text] [Related]
19. TRAF6 regulates proliferation of stromal cells in the transition and peripheral zones of benign prostatic hyperplasia via Akt/mTOR signaling.
Shi YF; Yu DJ; Jiang CY; Wang XJ; Zhu YP; Zhao RZ; Lv Z; Sun XW
Prostate; 2018 Feb; 78(3):193-201. PubMed ID: 29171041
[TBL] [Abstract][Full Text] [Related]
20. The value of power Doppler imaging to predict the histologic components of benign prostatic hyperplasia.
Hayami S; Ushiyama T; Kurita Y; Kageyama S; Suzuki K; Fujita K
Prostate; 2002 Oct; 53(2):168-74. PubMed ID: 12242732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
